Spots Global Cancer Trial Database for Mebendazole as Adjuvant Treatment for Colon Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Mebendazole as Adjuvant Treatment for Colon Cancer
Official Title: Clinical Study Evaluating Mebendazole as Adjuvant Therapy in Patients With Colorectal Cancer
Study ID: NCT03925662
Conditions
Study Description
Brief Summary: mebendazole treating colon cancer
Detailed Description: mebendazole as adjuvant treatment for colon cancer
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Sherief Abd-Elsalam, Cairo, , Egypt
Contact Details
Name: Reham El-ghoneimy, Msc
Affiliation: Tanta University - Faculty of Pharmacy
Role: PRINCIPAL_INVESTIGATOR
Name: Sahar Hegazy, Prof
Affiliation: Tanta University - Faculty of Pharmacy
Role: PRINCIPAL_INVESTIGATOR
Name: Gamal el-azab, Prof
Affiliation: Tanta University - Faculty of Pharmacy
Role: STUDY_DIRECTOR
Name: Fatma Zakaria, Prof
Affiliation: Clinical Oncology department. Tanta University.
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
